FYI...NUVO...Somoeone earlier stated that the NUVO move was associated with news that they would be releasing next week. Seems like the animal study information was released this past weekend......
"Another standout, shares of Nuvelo Inc. (NUVO : nuvelo inc com :
NUVO5.40, +1.68, +45.2%) rocketed more than 50% to $5.56. The small biotech group presented data from animal studies for its NU206 drug candidate at a scientific meeting of the American Association for Cancer Research on Saturday. The company has been testing the compound for a variety of applications, including cancer and inflammatory bowel disease. "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.